PHILADELPHIA (February 21, 2014) – The Temple Bone Marrow Transplant Program has once again earned accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT) – the primary certification agency for bone marrow transplantation – signifying excellence in all quality aspects of patient care and collection practices related to cellular therapy treatments. The accreditation is effective for three years beginning January 16, 2014.
"This achievement marks the fifth consecutive time that Temple's Bone Marrow Transplant Program has earned FACT accreditation, which is truly a testament to the high quality of our clinical and collection services for therapeutic bone marrow and peripheral blood products for the transplantation procedures that we perform," said Henry Chi Hang Fung, MD, FRCPE, Clinical Leader of the Blood Cancers Program and the Hematologic Oncology Service Line at Fox Chase Cancer Center, and Director of the Temple Bone Marrow Transplant Program.
"Our year-over-year achievement of FACT accreditation earns the confidence of physicians and patients by certifying Temple's evidence-based standards and practices for the management of patients and donors as well as the collection and administration of these life-saving cells," added Dr. Fung.
Temple's Bone Marrow Transplant program is run by Temple University Hospital and is located at Temple University Health System's Jeanes Hospital.